Avatrombopag 20 MG ( DrugBank: Avatrombopag )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
60再生不良性貧血2

60. 再生不良性貧血


臨床試験数 : 245 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05571332
(ClinicalTrials.gov)
June 28, 202228/8/2022Efficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver FunctionEfficacy and Safety of Avatrombopag Combined With IST for the Treatment of HAAA and SAA With Abnormal Liver FunctionAplastic AnemiaDrug: Avatrombopag 20 MG Oral TabletInstitute of Hematology & Blood Diseases HospitalNULLRecruiting18 Years70 YearsAll39N/AChina
2NCT04728789
(ClinicalTrials.gov)
February 1, 20211/12/2020Avatrombopag Usage in NSAAEfficacy and Safety of Avatrombopag in Non-severe Aplastic Anemia - a Multicenter Prospective Single Arm StudyAplastic Anemia;Drug EffectDrug: Avatrombopag 20 MGPeking Union Medical College HospitalNULLNot yet recruiting18 Years75 YearsAll40Phase 2/Phase 3China